Functional role of amino-terminal serine16 and serine27 of G alphaZ in receptor and effector coupling.
The alpha subunit of Gz (alpha(z)) harbors two N-terminal serine residues (at positions 16 and 27) that serve as protein kinase C-mediated phosphorylation sites. The cognate residues in the alpha subunit of Gt1 provide binding surfaces for the beta1 subunit. We used three serine-to-alanine mutants of alpha(z) to investigate the functional importance of the two N-terminal serine residues. Wild-type or mutant alpha(z) was transiently coexpressed with different receptors and adenylyl cyclase isozymes in human embryonic kidney 293 cells, and agonist-dependent regulation of cyclic AMP accumulation was examined in a setting where all endogenous alpha subunits of G1 were inactivated by pertussis toxin. Replacement of one or both serine residues by alanine did not alter the ability of alpha(z) to interact with delta-opioid, dopamine D2, or adenosine A1 receptors. Its capacity to inhibit endogenous and type VI adenylyl cyclases was also unaffected. Functional release of betagamma subunits from the mutant alpha(z) subunits was not impaired because they transduced betagamma-mediated stimulation of type II adenylyl cyclase. Constitutively active mutants of all four alpha(z) subunits were constructed by the introduction of a Q205L mutation. The activated mutants showed differential abilities to inhibit human choriogonadotropin-mediated cyclic AMP accumulation in luteinizing hormone receptor-transfected cells. Loss of both serine residues, but not either one alone, impaired the receptor-independent inhibition of adenylyl cyclase by the GTPase-deficient mutant. Thus, replacement of the amino-terminal serine residues of alpha(z) has no apparent effect on receptor-mediated responses, but these serine residues may be essential for ensuring transition of alpha(z) into the active conformation.
Ho
M K
MK
Department of Biology, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon.
Wong
Y H
YH
D037361:Adenylate Cyclase Toxin; D000262:Adenylyl Cyclases / Q000378:metabolism; D000595:Amino Acid Sequence; D000700:Analgesics / Q000494:pharmacology; D002478:Cells, Cultured; D000242:Cyclic AMP / Q000378:metabolism; D018491:Dopamine Agonists / Q000494:pharmacology; D020881:Enkephalin, D-Penicillamine (2,5)-; D004745:Enkephalins / Q000494:pharmacology; D019204:GTP-Binding Proteins / Q000737:chemistry* / Q000235:genetics / Q000378:metabolism*; D006160:Guanosine Triphosphate / Q000378:metabolism; D006801:Humans; D007223:Infant; D007668:Kidney / Q000166:cytology; D008969:Molecular Sequence Data; D016296:Mutagenesis / Q000502:physiology; D037342:Pertussis Toxin; D010766:Phosphorylation; D019257:Quinpirole / Q000494:pharmacology; D017465:Receptors, Opioid, delta / Q000819:agonists; D012694:Serine / Q000502:physiology*; D015398:Signal Transduction / Q000502:physiology; D010566:Virulence Factors, Bordetella / Q000494:pharmacology
D037361:Adenylate Cyclase Toxin; D000700:Analgesics; D018491:Dopamine Agonists; D004745:Enkephalins; D017465:Receptors, Opioid, delta; D010566:Virulence Factors, Bordetella; D019257:Quinpirole; D012694:Serine; D006160:Guanosine Triphosphate; D020881:Enkephalin, D-Penicillamine (2,5)-; D000242:Cyclic AMP; D037342:Pertussis Toxin; D019204:GTP-Binding Proteins; D000262:Adenylyl Cyclases